Zhejiang Jingxin Pharmaceutical Co., Ltd. (SHE: 002020)
China flag China · Delayed Price · Currency is CNY
11.05
-0.11 (-0.99%)
Sep 9, 2024, 1:43 PM CST

Zhejiang Jingxin Pharmaceutical Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Jan '23 Jan '22 Dec '20 Dec '19 2018 - 2014
Market Capitalization
9,50610,9529,9488,1886,6377,379
Upgrade
Market Cap Growth
-18.33%10.10%21.49%23.37%-10.06%20.46%
Upgrade
Enterprise Value
8,7569,9618,4086,4474,8715,283
Upgrade
Last Close Price
11.0412.3911.648.787.417.74
Upgrade
PE Ratio
13.4717.2115.1111.719.0312.72
Upgrade
PS Ratio
2.262.742.632.362.042.02
Upgrade
PB Ratio
1.681.981.921.671.691.99
Upgrade
P/FCF Ratio
17.4040.0729.24-245.3837.0437.28
Upgrade
P/OCF Ratio
10.5313.8111.6221.9312.9313.79
Upgrade
EV/Sales Ratio
2.082.492.221.861.501.45
Upgrade
EV/EBITDA Ratio
9.9712.7910.979.037.588.92
Upgrade
EV/EBIT Ratio
14.0017.2013.7011.169.3810.87
Upgrade
EV/FCF Ratio
16.0336.4524.71-193.2027.1826.68
Upgrade
Debt / Equity Ratio
0.090.060.060.040.080.10
Upgrade
Debt / EBITDA Ratio
0.560.410.380.270.470.61
Upgrade
Debt / FCF Ratio
0.901.180.87-5.811.681.82
Upgrade
Asset Turnover
0.530.520.540.570.580.69
Upgrade
Inventory Turnover
2.912.792.442.622.783.29
Upgrade
Quick Ratio
0.861.101.371.831.681.72
Upgrade
Current Ratio
1.241.621.812.322.021.97
Upgrade
Return on Equity (ROE)
13.02%11.64%13.26%13.99%17.10%14.30%
Upgrade
Return on Assets (ROA)
4.88%4.72%5.52%5.91%5.75%5.71%
Upgrade
Return on Capital (ROIC)
6.61%6.39%7.26%7.74%7.82%7.78%
Upgrade
Earnings Yield
7.42%5.65%6.66%7.48%9.84%7.05%
Upgrade
FCF Yield
5.75%2.50%3.42%-0.41%2.70%2.68%
Upgrade
Dividend Yield
2.69%2.42%2.58%3.42%3.94%3.77%
Upgrade
Payout Ratio
36.63%41.74%39.04%37.90%36.05%39.76%
Upgrade
Buyback Yield / Dilution
0.25%0.06%-5.31%-2.55%6.90%1.28%
Upgrade
Total Shareholder Return
2.94%2.48%-2.73%0.87%10.84%5.05%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.